167 related articles for article (PubMed ID: 16651701)
1. A missing link between a high salt intake and blood pressure increase.
Katori M; Majima M
J Pharmacol Sci; 2006; 100(5):370-90. PubMed ID: 16651701
[TBL] [Abstract][Full Text] [Related]
2. Role of the renal kallikrein-kinin system in the development of hypertension.
Katori M; Majima M
Immunopharmacology; 1997 Jun; 36(2-3):237-42. PubMed ID: 9228552
[TBL] [Abstract][Full Text] [Related]
3. Renal (tissue) kallikrein-kinin system in the kidney and novel potential drugs for salt-sensitive hypertension.
Katori M; Majima M
Prog Drug Res; 2014; 69():59-109. PubMed ID: 25130040
[TBL] [Abstract][Full Text] [Related]
4. Role of the renal kallikrein-kinin system in the development of salt-sensitive hypertension.
Katori M; Majima M; Hayashi I; Fujita T; Yamanaka M
Biol Chem; 2001 Jan; 382(1):61-4. PubMed ID: 11258674
[TBL] [Abstract][Full Text] [Related]
5. Crucial suppressive role of renal kallikrein-kinin system in development of salt-sensitive hypertension.
Katori M; Majima M; Hayashi I
Biol Res; 1998; 31(3):143-9. PubMed ID: 9830501
[TBL] [Abstract][Full Text] [Related]
6. A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.
Katori M; Majima M
Pharmaceuticals (Basel); 2010 Jan; 3(1):59-109. PubMed ID: 27713243
[TBL] [Abstract][Full Text] [Related]
7. Are all individuals equally sensitive in the blood pressure to high salt intake? (Review article).
Katori M; Majima M
Acta Physiol Hung; 2008 Sep; 95(3):247-65. PubMed ID: 18788465
[TBL] [Abstract][Full Text] [Related]
8. The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension.
Katori M; Majima M
Crit Rev Clin Lab Sci; 2003 Feb; 40(1):43-115. PubMed ID: 12627748
[TBL] [Abstract][Full Text] [Related]
9. Facilitation of renal kallikrein-kinin system prevents the development of hypertension by inhibition of sodium retention.
Majima M; Hayashi I; Fujita T; Ito H; Nakajima S; Katori M
Immunopharmacology; 1999 Oct; 44(1-2):145-52. PubMed ID: 10604538
[TBL] [Abstract][Full Text] [Related]
10. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
Chen K; Zhang X; Dunham EW; Zimmerman BG
Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
[TBL] [Abstract][Full Text] [Related]
11. Hypertension in Dahl salt-sensitive rats: biochemical and immunohistochemical studies.
Bouhnik J; Richoux JP; Huang H; Savoie F; Baussant T; Alhenc-Gelas F; Corvol P
Clin Sci (Lond); 1992 Jul; 83(1):13-22. PubMed ID: 1325316
[TBL] [Abstract][Full Text] [Related]
12. The kallikrein-kinin system as a regulator of cardiovascular and renal function.
Rhaleb NE; Yang XP; Carretero OA
Compr Physiol; 2011 Apr; 1(2):971-93. PubMed ID: 23737209
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of kinin degradation on the luminal side of renal tubules reduces high blood pressure in deoxycorticosterone acetate salt-treated rats.
Nakajima S; Ito H; Hayashi I; Kuribayashi Y; Okumura T; Yajima Y; Katori M; Majima M
Clin Exp Pharmacol Physiol; 2000; 27(1-2):80-7. PubMed ID: 10696533
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic blockade of the kallikrein-kinin system on the development of hypertension in rats.
Majima M; Katori M
Hypertension; 2001 Oct; 38(4):E21-3. PubMed ID: 11641321
[No Abstract] [Full Text] [Related]
15. Cellular and functional aspects of the renal kallikrein system in health and disease.
Vio CP; Olavarría V; González C; Nazal L; Córdova M; Balestrini C
Biol Res; 1998; 31(3):305-22. PubMed ID: 9830518
[TBL] [Abstract][Full Text] [Related]
16. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.
Levy SB; Lilley JJ; Frigon RP; Stone RA
J Clin Invest; 1977 Jul; 60(1):129-38. PubMed ID: 874078
[TBL] [Abstract][Full Text] [Related]
17. [Kallikrein-kinin system, the kidney and arterial pressure].
Alhenc-Gelas F; Baussant T; Gardes J; Corvol P
Nephrologie; 1988; 9(1):3-7. PubMed ID: 2839786
[TBL] [Abstract][Full Text] [Related]
18. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
Marzecka J
Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
[TBL] [Abstract][Full Text] [Related]
19. Roles of the renal kallikrein-kinin system in salt-sensitive hypertension.
Katori M; Majima M
Hypertension; 2004 Dec; 44(6):e12. PubMed ID: 15492137
[No Abstract] [Full Text] [Related]
20. Ebelactone B, an inhibitor of urinary carboxypeptidase Y-like kininase, prevents the development of deoxycorticosterone acetate-salt hypertension in rats.
Majima M; Ikeda Y; Kuribayashi Y; Mizogami S; Katori M; Aoyagi T
Eur J Pharmacol; 1995 Sep; 284(1-2):1-11. PubMed ID: 8549611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
